GeoVax Labs, Inc. (GOVX) Financials
GOVX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 4.6 million | 2.9 million |
| March 31, 2026 | 3.0 million | 2.5 million |
| Dec. 31, 2025 | 6.3 million | 2.5 million |
| Sept. 30, 2025 | 6.7 million | 1.8 million |
GOVX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -3.7 million | 163746 |
| March 31, 2026 | -3.5 million | 219317 |
| Dec. 31, 2025 | -5.0 million | 252124 |
| Sept. 30, 2025 | -6.2 million | 277546 |
GOVX Net Income
No data available :(
GOVX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 3.1 million | - | 169568 |
| March 31, 2026 | 1.3 million | - | 394571 |
| Dec. 31, 2025 | 3.1 million | - | 843170 |
| Sept. 30, 2025 | 5.0 million | - | - |
GOVX Shares Outstanding
GOVX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.1 million | 1.3 million | - |
| March 31, 2026 | 4 | 3.9 million | 1.4 million | - |
| Dec. 31, 2025 | 4 | 3.0 million | 1.5 million | - |
| Sept. 30, 2025 | 5 | 5.0 million | 1.3 million | - |
GOVX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 12076 |
| March 31, 2026 | - | 3.9 million |
| Dec. 31, 2025 | - | -33723 |
| Sept. 30, 2025 | - | 5.0 million |
GOVX
Price: $0.65
52 week price:
Earnings Per Share: -5.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 421264
Market Capitalization: 5.7 million